EMBC Court News: Embecta Class Action Lawsuit Alleges Securities Fraud on behalf of Investors with Losses

A securities fraud class action lawsuit has been filed on behalf of Embecta investors after its stock plummeted over 57% because Embecta allegedly misled investors regarding the strength of its insulin pen needle product category. NEW YORK, July 14, 2026 /PRNewswire/ -- Leading securities...